Le Lézard
Classified in: Health, Covid-19 virus
Subjects: STP, AVO

The Ticktin Law Group Petitions Gov. DeSantis To Release Non-Violent Offender A Few Months Early From 15-Year Sentence As He Fears Catching COVID-19 Just As Florida Prison Boss Tests Positive

DEERFIELD BEACH, Fla., Aug. 3, 2020 /PRNewswire/ -- The Ticktin Law Group has officially urged Gov. Ron DeSantis to show clemency to a non-violent offender who has only seven months left to serve on a 15-year sentence while living in mortal fear of contracting COVID-19 from other prisoners.  Florida Department of Corrections Secretary Mark Inch was reported to be facing the highly infectious disease himself.

On behalf of the prisoner and author William Hawley, the law firm filed a writ of mandamus requesting the governor and The Florida Office of Executive Clemency to grant a commutation of sentence to release him a few months early so he won't catch the virus becoming rampant among prison populations nationwide.   

The writ filed in the Second Judicial Circuit in Leon County affirms Hawley is in constant fear for his life as prisoners around him fall ill. It cites Hawley as a model prisoner who throughout the course of serving this sentence has assisted Federal and State Government agencies on serious investigations and prosecutions of highly violent crimes.

"Why continue to hold a non-violent offender and highly skilled author to the last minute of his sentence when he has risked so much to help the criminal justice system to prosecute highly violent offenders at his own peril," said Peter Ticktin, senior partner, The Ticktin Law Group, an author himself of What Makes Trump Tick.  

Hawley wrote Dursturbed, a book about alleged serial killer, multimillionaire Robert Durst, soon to go on trial for murder in California and Hawley believes his book could shed light on Durst's depravity.  A model inmate, he regularly consults his Warden on prison and inmate safety and is taking classes at a top university.

The writ seeks to compel Gov. DeSantis to resume holding hearings regarding requests for commutation of sentences or clemency or show why these hearings are not going forward when the pandemic puts many prisoners in jeopardy.

Petitioner Hawley is a Florida resident serving a Florida Criminal Sentence.  His petition affirms Gov. DeSantis has executive clemency power pursuant to the state constitution and oversees Florida Department of Executive Clemency.

The writ questions why the governor is not acting to release a non-violent offender just a few months early to avoid contracting the killer virus.

Media contact: Tom Madden 561-702-4999; tmadden@transmediagroup.com.

SOURCE The Ticktin Law Group

These press releases may also interest you

at 16:20
In the Phase 3 VALOR study, the primary endpoint as measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) did not reach statistical significance; however, signs of reduced disease progression across multiple...

at 16:20
Ionis Pharmaceuticals, Inc. partner Biogen today announced topline results from its placebo-controlled pivotal Phase 3 VALOR study of tofersen (BIIB067), an investigational antisense medicine being evaluated for people with superoxide dismutase 1...

16 oct 2021
Core One Labs Inc. , , (the "Company") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, congratulates Seattle's city...

16 oct 2021
Neurocrine Biosciences, Inc.  today announced that it will present key information from its movement disorder treatments for Parkinson's disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting...

16 oct 2021
HLNY's highest recognition, the "Award of Distinction" will be presented to Arthur Gianelli, FACHE, Chief Transformation Officer of Mount Sinai Health System and President of Mount Sinai Morningside. This award recognizes a healthcare executive who...

16 oct 2021
Regulated Information ? Inside Information ? UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License...

News published on 3 august 2020 at 09:35 and distributed by: